| 102036-1 | Abnormal Prion Protein Document (CSF, rt-quic) | MICRO |
| 102038-7 | ROS proto-oncogene 1 mutations found or Tissue (Blood, molecular genetics method nominal) | MOLPATH.REARRANGE |
| 102039-5 | MET gene amplification or Tissue (Blood, molgen) | MOLPATH |
| 10204-6 | Physical findings of Pelvis Narrative | H&P.PX |
| 102040-3 | Polygenic risk score (PRS) | CLIN.RISK |
| 102041-1 | Carboxy tetrahydrocannabinol Delta 9/Creatinine (Urine) | DRUG/TOX |
| 102042-9 | Lung cancer panel | PANEL.MOLPATH |
| 102043-7 | Surgical oncology of lung cancer synoptic report | SURG |
| 102044-5 | Surgical oncology of stomach cancer synoptic report | SURG |
| 102045-2 | Synoptic report for adrenal gland cancer surgery | SURG |
| 102046-0 | Surgical oncology of sarcoma cancer synoptic report | SURG |
| 102047-8 | Surgical oncology of rectum cancer synoptic report | SURG |
| 102048-6 | SARS coronavirus 2 and Respiratory syncytial virus Ag in Nasopharynx (qualitative, immunofluorescence) | MICRO |
| 102049-4 | Hereditary sensory and autonomic neuropathy type 1 panel - Serum (lc/ms/ms) | PANEL.CHEM |
| 10205-3 | Physical findings of Rectum Narrative | H&P.PX |
| 102050-2 | Diabetic diagnosis | MISC |
| 102051-0 | 1-deoxysphinganine (lc/ms/ms) | CHEM |
| 102052-8 | 1-Deoxysphingosine (lc/ms/ms) | CHEM |
| 102053-6 | 1-deoxymethylsphinganine (lc/ms/ms) | CHEM |
| 102054-4 | 1-deoxymethylsphingosine (lc/ms/ms) | CHEM |
| 102055-1 | Sphinganine (lc/ms/ms) | CHEM |
| 102056-9 | Sphingosine (lc/ms/ms) | CHEM |
| 102057-7 | Sphingolipid panel - Serum | PANEL.CHEM |
| 102058-5 | Perfluorohexanoate (lc/ms/ms) | DRUG/TOX |
| 102059-3 | Perfluorobutane Sulfonic Acid (lc/ms/ms) | DRUG/TOX |
| 10206-1 | Physical findings of Skin Narrative | H&P.PX |
| 102060-1 | Perfluoroheptanoate (lc/ms/ms) | DRUG/TOX |
| 102061-9 | 4,8-Dioxa-3H-perfluorononanoate (lc/ms/ms) | DRUG/TOX |
| 102062-7 | Branched PFOA isomers (lc/ms/ms) | DRUG/TOX |
| 102063-5 | Linear PFOA Isomer (lc/ms/ms) | DRUG/TOX |
| 102064-3 | Total perfluorohexanoic acid isomers | DRUG/TOX |
| 102065-0 | Perfluorohexane sulfonate (lc/ms/ms) | DRUG/TOX |
| 102066-8 | Perfluorononanoate (lc/ms/ms) | DRUG/TOX |
| 102067-6 | Perfluoroheptane sulfonate | DRUG/TOX |
| 102068-4 | Perfluoroundecanoate (lc/ms/ms) | DRUG/TOX |
| 102069-2 | Perfluorodecanoate (lc/ms/ms) | DRUG/TOX |
| 10207-9 | Physical findings of Thorax and Lungs Narrative | H&P.PX |
| 102070-0 | Branched PFOS Isomers (lc/ms/ms) | DRUG/TOX |
| 102071-8 | Linear PFOS Isomer (lc/ms/ms) | DRUG/TOX |
| 102072-6 | 2-N-Methyl-perfluorooctanesulfonamide acetate (lc/ms/ms) | DRUG/TOX |
| 102073-4 | Perfluorododecanoate (lc/ms/ms) | DRUG/TOX |
| 102074-2 | Perfluorooctane Sulfonamide (lc/ms/ms) | DRUG/TOX |
| 102075-9 | NASEM Summation Value | DRUG/TOX |
| 102076-7 | Insulin --3.5 hours post 75 g glucose PO | CHAL |
| 102078-3 | CAR-T therapy panel - Specimen | PANEL.DRUG/TOX |
| 102079-1 | CAR-T dose | DRUG/TOX |
| 10208-7 | Physical findings of Vessels Narrative | H&P.PX |
| 102080-9 | CAR-T cell product unit (Blood) | BLDBK |
| 102081-7 | CAR-T cells total product unit (Blood) | BLDBK |
| 102082-5 | Alpha-1-Antitrypsin Proteotype Panel - Serum or Plasma | PANEL.CHEM |